RD.06.SPR.118161 – A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Subjects with Moderate-to-Severe Atopic Dermatitis

RD.06.SPR.202685 – A study to assess the efficacy and safety of nemolizumab (CD14152) insubjects with prurigo nodularis (PN)

RD.06.SPR.202699 – A long-term study to assess the safety and efficacy of nemolizumab(CD14152) in subjects with prurigo nodularis (PN)